Your browser doesn't support javascript.
loading
Porphyran Attenuates Neuronal Loss in the Hippocampal CA1 Subregion Induced by Ischemia and Reperfusion in Gerbils by Inhibiting NLRP3 Inflammasome-Mediated Neuroinflammation.
Kim, Dae Won; Lee, Tae-Kyeong; Ahn, Ji Hyeon; Yang, Se-Ran; Shin, Myoung Cheol; Cho, Jun Hwi; Won, Moo-Ho; Kang, Il Jun; Park, Joon Ha.
Afiliação
  • Kim DW; Department of Biochemistry and Molecular Biology, Research Institute of Oral Sciences, College of Dentistry, Gangneung-Wonju National University, Gangneung 25457, Republic of Korea.
  • Lee TK; Department of Food Science and Nutrition, Hallym University, Chuncheon 24252, Republic of Korea.
  • Ahn JH; Department of Physical Therapy, College of Health Science, Youngsan University, Yangsan 50510, Republic of Korea.
  • Yang SR; Department of Cardiovascular Surgery, School of Medicine, Kangwon National University, Chuncheon 24341, Republic of Korea.
  • Shin MC; Department of Emergency Medicine, Kangwon National University Hospital, School of Medicine, Kangwon National University, Chuncheon 24289, Republic of Korea.
  • Cho JH; Department of Emergency Medicine, Kangwon National University Hospital, School of Medicine, Kangwon National University, Chuncheon 24289, Republic of Korea.
  • Won MH; Department of Emergency Medicine, Kangwon National University Hospital, School of Medicine, Kangwon National University, Chuncheon 24289, Republic of Korea.
  • Kang IJ; Department of Food Science and Nutrition, Hallym University, Chuncheon 24252, Republic of Korea.
  • Park JH; Department of Anatomy, College of Korean Medicine, Dongguk University, 123 Dongdae-ro, Gyeongju 38066, Republic of Korea.
Mar Drugs ; 22(4)2024 Apr 11.
Article em En | MEDLINE | ID: mdl-38667787
ABSTRACT
Porphyran, a sulfated polysaccharide found in various species of marine red algae, has been demonstrated to exhibit diverse bioactivities, including anti-inflammatory effects. However, the protective effects of porphyran against cerebral ischemia and reperfusion (IR) injury have not been investigated. The aim of this study was to examine the neuroprotective effects of porphyran against brain IR injury and its underlying mechanisms using a gerbil model of transient forebrain ischemia (IR in the forebrain), which results in pyramidal cell (principal neuron) loss in the cornu ammonis 1 (CA1) subregion of the hippocampus on day 4 after IR. Porphyran (25 and 50 mg/kg) was orally administered daily for one week prior to IR. Pretreatment with 50 mg/kg of porphyran, but not 25 mg/kg, significantly attenuated locomotor hyperactivity and protected pyramidal cells located in the CA1 area from IR injury. The pretreatment with 50 mg/kg of porphyran significantly suppressed the IR-induced activation and proliferation of microglia in the CA1 subregion. Additionally, the pretreatment significantly inhibited the overexpressions of nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing protein-3 (NLRP3) inflammasome complex, and pro-inflammatory cytokines (interleukin 1 beta and interleukin 18) induced by IR in the CA1 subregion. Overall, our findings suggest that porphyran exerts neuroprotective effects against brain IR injury, potentially by reducing the reaction (activation) and proliferation of microglia and reducing NLRP3 inflammasome-mediated neuroinflammation.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Sefarose / Traumatismo por Reperfusão / Gerbillinae / Fármacos Neuroprotetores / Região CA1 Hipocampal / Inflamassomos / Proteína 3 que Contém Domínio de Pirina da Família NLR / Doenças Neuroinflamatórias Limite: Animals Idioma: En Revista: Mar Drugs Assunto da revista: BIOLOGIA / FARMACOLOGIA Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Sefarose / Traumatismo por Reperfusão / Gerbillinae / Fármacos Neuroprotetores / Região CA1 Hipocampal / Inflamassomos / Proteína 3 que Contém Domínio de Pirina da Família NLR / Doenças Neuroinflamatórias Limite: Animals Idioma: En Revista: Mar Drugs Assunto da revista: BIOLOGIA / FARMACOLOGIA Ano de publicação: 2024 Tipo de documento: Article